Literature DB >> 7876093

Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor.

H Y Song1, J D Dunbar, Y X Zhang, D Guo, D B Donner.   

Abstract

The yeast-based two hybrid has been used to identify a novel protein that binds to the intracellular domain of the type 1 receptor for tumor necrosis factor (TNFR-1IC). The TNF receptor-associated protein, TRAP-1, shows strong homology to members of the 90-kDa family of heat shock proteins. After in vitro transcription/translation and 35S labeling, TRAP-1 was precipitated using a fusion protein consisting of glutathione S-transferase and TNFR-1IC, showing that the two proteins directly interact. The ability of deletion mutants of TNFR-1 to interact with TRAP-1 was tested using the two hybrid system. This showed that the amino acid sequences that mediate binding are diffusely distributed outside of the domain in the C terminus of TNFR-1IC that signals cytotoxicity. The 2.4-kilobase TRAP-1 mRNA was variably expressed in skeletal muscle, liver, heart, brain, kidney, pancreas, lung, and placenta. TRAP-1 mRNA was also detected in each of eight different transformed cell lines. Identification of TRAP-1 may be an important step toward defining how TNFR-1, which does not contain protein tyrosine kinase activity, transmits its message to signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876093

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  81 in total

Review 1.  Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones.

Authors:  H J Ochel; K Eichhorn; G Gademann
Journal:  Cell Stress Chaperones       Date:  2001-04       Impact factor: 3.667

2.  Involvement of FAN in TNF-induced apoptosis.

Authors:  B Ségui; O Cuvillier; S Adam-Klages; V Garcia; S Malagarie-Cazenave; S Lévêque; S Caspar-Bauguil; J Coudert; R Salvayre; M Krönke; T Levade
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

3.  Hsp90 inhibitors as senolytic drugs to extend healthy aging.

Authors:  Heike Fuhrmann-Stroissnigg; Laura J Niedernhofer; Paul D Robbins
Journal:  Cell Cycle       Date:  2018-07-23       Impact factor: 4.534

4.  The regulatory particle of the Saccharomyces cerevisiae proteasome.

Authors:  M H Glickman; D M Rubin; V A Fried; D Finley
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

5.  Complexity of Hsp90 in organelle targeting.

Authors:  Constantinos Prassinos; Kosmas Haralampidis; Dimitra Milioni; Despina Samakovli; Konstantinos Krambis; Polydefkis Hatzopoulos
Journal:  Plant Mol Biol       Date:  2008-03-27       Impact factor: 4.076

6.  The charged region of Hsp90 modulates the function of the N-terminal domain.

Authors:  T Scheibel; H I Siegmund; R Jaenicke; P Ganz; H Lilie; J Buchner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 7.  Molecular chaperones in the etiology and therapy of cancer.

Authors:  C Soti; P Csermely
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

8.  Crystallization and preliminary X-ray diffraction analysis of Trap1 complexed with Hsp90 inhibitors.

Authors:  Hanbin Jeong; Byoung Heon Kang; Changwook Lee
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-11-28       Impact factor: 1.056

9.  Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.

Authors:  B S Sylla; S C Hung; D M Davidson; E Hatzivassiliou; N L Malinin; D Wallach; T D Gilmore; E Kieff; G Mosialos
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

10.  Substitution of only two residues of human Hsp90alpha causes impeded dimerization of Hsp90beta.

Authors:  Takeshi Kobayakawa; Shin-Ichi Yamada; Akio Mizuno; Takayuki K Nemoto
Journal:  Cell Stress Chaperones       Date:  2008-02-12       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.